Description: Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.
Home Page: www.surgalign.com
SRGA Technical Analysis
520 Lake Cook Road
Deerfield,
IL
60015
United States
Phone:
224 303 4651
Officers
| Name | Title |
|---|---|
| Mr. Terry M. Rich | Pres, CEO & Director |
| Mr. Christopher Thunander | VP & Chief Accounting Officer |
| Mr. Enrico Sangiorgio | Exec. VP of International |
| Mr. William Scott Durall | Chief Commercial Officer |
| Mr. David B. Lyle | Chief Financial Officer |
| Mr. Bob Watkins | Chief Technology Officer |
| Mr. Paolo G. Amoruso | Chief Legal Officer, Gen. Counsel & Corp. Sec. |
| Ms. Suzanne C. Zoumaras | Chief People Officer |
| Mr. John N. Varela | Exec. VP of Global Operations |
| Mr. Olivier M. Visa | Pres of Global OEM |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 526.3158 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.7929 |
| Price-to-Sales TTM: | 0.2498 |
| IPO Date: | 2000-08-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 231 |